Matthew Peterson
11Patents
3h-index
39Co-inventors
56Inventor score
Filing activity: Oct 5, 2007 → Jul 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11465969B2 | Salts and crystal forms of omecamtiv mecarbil | Chemistry; Metallurgy | 13 | Active |
| US10189829B2 | Inhibiting agents for Bruton's tyrosine kinase | Chemistry; Metallurgy | 6 | Active |
| US10961237B2 | Inhibiting agents for Bruton's tyrosine kinase | Chemistry; Metallurgy | 4 | Active |
| US11427577B2 | Inhibiting agents for Bruton's tyrosine kinase | Chemistry; Metallurgy | 2 | Active |
| US11142516B2 | Process for the preparation of an amino-pyrimidine and intermediates thereof | Chemistry; Metallurgy | 0 | Active |
| US9981988B2 | Polymorphic forms and co-crystals of a c-Met inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11827600B2 | Crystalline forms of trofinetide | Chemistry; Metallurgy | 0 | Active |
| US7632963B2 | Crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate | Chemistry; Metallurgy | 0 | Active |
| US10053452B2 | Crystalline forms of N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine salts and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11858926B2 | Inhibiting agents for bruton's tyrosine kinase | Chemistry; Metallurgy | 0 | Active |
| US10344041B2 | Polymorphic forms and co-crystals of a c-Met inhibitor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.